SCHEMBL6325483

SCHEMBL6325483

N=c1ccn(-c2ncc3cccnc3n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.33
KDM4E B2RXH2 2/20 0.33
LMNA P02545 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
PDE10A Q9Y233 1/20 0.31
GMNN O75496 1/20 0.31
TP53 P04637 1/20 0.31
HSP90AA1 P07900 1/20 0.31
MMP2 P08253 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
MAPT P10636 1/20 0.31
MMP9 P14780 1/20 0.31
ALOX15 P16050 1/20 0.31
TSHR P16473 1/20 0.31
NFKB1 P19838 1/20 0.31
MMP8 P22894 1/20 0.31
CCR1 P32246 1/20 0.31
THPO P40225 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29405642 0.74 LMNA (0.40) ALDH1A1KDM4ELMNAMEN1KMT2A
SCHEMBL11078075 0.67 KDM4E (0.54) ALDH1A1KDM4E
SCHEMBL29536760 0.64 NUDT1 (0.42) ALDH1A1KDM4ELMNAMEN1KMT2A
SCHEMBL5489083 0.64 NUDT1 (0.42) ALDH1A1KDM4ELMNAMEN1KMT2A
SCHEMBL29808133 0.64 ALDH1A1 (0.41) ALDH1A1KDM4ELMNAMEN1KMT2A
SCHEMBL5794086 0.64 PSMD14 (0.42) ALDH1A1KDM4ELMNAMEN1KMT2A
SCHEMBL4143004 0.64 ALDH1A1 (0.41) ALDH1A1KDM4ELMNAMEN1KMT2A
SCHEMBL3001006 0.64 KDM4E (0.44) ALDH1A1KDM4ELMNAMEN1KMT2A
SCHEMBL22479754 0.64 ALDH1A1 (0.41) ALDH1A1KDM4ELMNAMEN1KMT2A
SCHEMBL2408295 0.64 RPS6KA5 (0.41) ALDH1A1KDM4ELMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6960662-B2 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido[2,3-d]pyrimidin-7-ones WARNER-LAMBERT COMPANY (US) 2005-11-01 US claimed
US-20030216415-A1 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido[2,3-d]pyrimidin-7-ones BEYLIN VLADIMIR GENUKH (US) 2003-11-20 US claimed
EP-1307451-A2 PROCESS FOR PREPARING 2-(4-PYRIDYL)AMINO-6-DIALKYLOXYPHENYL-PYRIDO 2,3-D]PYRIMIDIN-7-ONES WARNER-LAMBERT COMPANY LLC (US) 2003-05-07 EP claimed
WO-2002012237-A2 PROCESS FOR PREPARING 2-(4-PYRIDYL)AMINO-6-DIALKYLOXYPHENYL-PYRIDO[2,3-D]PYRIMIDIN-7-ONES WARNER-LAMBERT COMPANY (US) 2002-02-14 WO claimed
US-6960662-B2 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido[2,3-d]pyrimidin-7-ones WARNER-LAMBERT COMPANY (US) 2005-11-01 US disclosed
US-6960662-B2 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido[2,3-d]pyrimidin-7-ones WARNER-LAMBERT COMPANY (US) 2005-11-01 US disclosed
US-20030216415-A1 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido[2,3-d]pyrimidin-7-ones BEYLIN VLADIMIR GENUKH (US) 2003-11-20 US disclosed
EP-1307451-A2 PROCESS FOR PREPARING 2-(4-PYRIDYL)AMINO-6-DIALKYLOXYPHENYL-PYRIDO 2,3-D]PYRIMIDIN-7-ONES WARNER-LAMBERT COMPANY LLC (US) 2003-05-07 EP disclosed
WO-2002012237-A2 PROCESS FOR PREPARING 2-(4-PYRIDYL)AMINO-6-DIALKYLOXYPHENYL-PYRIDO[2,3-D]PYRIMIDIN-7-ONES WARNER-LAMBERT COMPANY (US) 2002-02-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216415-A1 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido[2,3-d]pyrimidin-7-ones DPYD, PDXK, PARP2 ALDH1A1 1034/4885KDM4E 1401/4885LMNA 3349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.